Health Policy and the Management of Antimicrobial Resistance in LMICs

Health Policy and the Management of Antimicrobial Resistance in LMICs

Submission deadline: 30th June 2020

In low and middle-income countries diagnostic, financial and infrastructural constraints mean the risk of emerging antimicrobial resistance (AMR) is high. This can lead to excessive or inappropriate use of anti-infectives, and so the implementation of appropriate policies to regulate their use and curb the emergence of resistant microbial threats is consequently more important now than ever. As recognised in the Goal 3 of the WHO's Sustainable Development Goals, concerted effort is required to tackle this threat, and to highlight the challenges and developments within antimicrobial drug policies in low and middle income countries.

More information: https://bit.ly/2WXZINR